Virazole drug may have potential to help COVID-19 patients recover: Bausch Health CEO

(5:53)

Ribavirin: Evidence-Based Health Information Related to COVID-19

(20:41)

Virology Lectures 2019 #20: Antivirals

(1:10:46)

As Remdesivir trial continues, combination therapies also tested

(2:42)

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir...

(6:12)

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained...

(7:42)

Pharmacology - ANTIVIRAL DRUGS (MADE EASY)

(15:10)

|Ribavirin| a drug commercial

(4:21)

MEDICAL MILESTONE: FIRST DRUG FOR SLEEP APNEA

(1:36)

Current Hepatitis C Treatments - Mayo Clinic

(1:18)

Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127...

(4:46)

Inventor of Sofosbuvir Discusses Limited Patient Access to Drug

(3:16)

RIBAVIRIN: Everything you need to know: Mechanism of Action- Hepatitis C- RSV- Copegus-Ribapak

(3:30)

Part II: New Medications for Hepatitis C

(1:31)

Triple antiviral drug shows early promise in treating Covid-19

(51)

Princeton Innovation: Inhibitors of hepatitis B and E virus infection

(1:44)

DAAs HCV treatment shift from hypoglycemic drugs to insulin therapy - Video abstract [ID 354023]

(2:4)

Sydney ID Distinguished Lecture - Professor Greg Dore

(55:7)

Direct-Acting Antiviral Combo Yields High Rates of SVR in Patients with Previous Virologic Failure

(2:1econd)

What Hepatitis C Patients Need to Know When Starting Sovaldi Regimen

(48)